title: Interleukin-18 gene polymorphism and markers of subclinical atherosclerosis. The Cardiovascular Risk in Young Finns Study.
abstract: OBJECTIVE
  Interleukin-18 (IL-18) is a pro-atherosclerotic cytokine. We wanted to evaluate whether IL-18 gene polymorphism associates independently of risk factors, with early subclinical markers of atherosclerosis (intima-media thickness (IMT), coronary artery compliance (CAC), and flow-mediated dilatation (FMD)) in a population of young healthy Caucasian adults.
  
  
  METHODS
  This study was based on the on-going Cardiovascular Risk in Young Finns Study consisting of 2260 young adults, mean age being 31.7 (range 24-39 years) (1247 women and 1013 men).
  
  
  RESULTS
  Five studied tagSNPs formed six major haplotypes, which accounted for 99.9% of all variation of the IL-18 gene. According to adjusted analysis of variance, the IL-18 gene polymorphism did not associate with subclinical atherosclerosis in the whole study population. However, one major haplotype associated differently among men and women with IMT (P = 0.011). Male carriers of a major CCTgT haplotype (n = 441) seemed to have a lower IMT when compared to the non-carriers (-0.016 mm, 95% confidence interval (CI) -0.028 to -0.004, P = 0.014). Among women no significant associations were observed.
  
  
  CONCLUSIONS
  Among all study subjects, the polymorphism of the IL-18 gene is not associated with subclinical markers of atherosclerosis. However, among men one major IL-18 haplotype seemed to associate with substantially lower IMT values.
authors.affiliation: Department of Clinical Chemistry, University of Tampere and Tampere University Hospital, Finland. jussi.hernesniemi@uta.fi
authors.forename: Jussi A
authors.initials: JA
authors.lastname: Hernesniemi
authors.forename: Arto
authors.initials: A
authors.lastname: Heikkilä
authors.forename: Olli T
authors.initials: OT
authors.lastname: Raitakari
authors.forename: Mika
authors.initials: M
authors.lastname: Kähönen
authors.forename: Markus
authors.initials: M
authors.lastname: Juonala
authors.forename: Nina
authors.initials: N
authors.lastname: Hutri-Kähönen
authors.forename: Jukka
authors.initials: J
authors.lastname: Marniemi
authors.forename: Jorma
authors.initials: J
authors.lastname: Viikari
authors.forename: Terho
authors.initials: T
authors.lastname: Lehtimäki
mesh_terms: D000328:Adult; D050197:Atherosclerosis / Q000453:epidemiology / Q000235:genetics* / Q000503:physiopathology; D002318:Cardiovascular Diseases / Q000453:epidemiology / Q000235:genetics / Q000503:physiopathology; D005260:Female; D005387:Finland / Q000453:epidemiology; D005787:Gene Frequency; D006239:Haplotypes; D006801:Humans; D020382:Interleukin-18 / Q000235:genetics*; D008297:Male; D011110:Polymorphism, Genetic; D012307:Risk Factors; D055815:Young Adult
chemical_list: D020382:Interleukin-18